NO964667L - Purin-6-on-derivater - Google Patents
Purin-6-on-derivaterInfo
- Publication number
- NO964667L NO964667L NO964667A NO964667A NO964667L NO 964667 L NO964667 L NO 964667L NO 964667 A NO964667 A NO 964667A NO 964667 A NO964667 A NO 964667A NO 964667 L NO964667 L NO 964667L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- formula
- purin
- stands
- residue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19541264A DE19541264A1 (de) | 1995-11-06 | 1995-11-06 | Purin-6-on-derivate |
Publications (2)
Publication Number | Publication Date |
---|---|
NO964667D0 NO964667D0 (no) | 1996-11-05 |
NO964667L true NO964667L (no) | 1997-05-07 |
Family
ID=7776713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO964667A NO964667L (no) | 1995-11-06 | 1996-11-05 | Purin-6-on-derivater |
Country Status (23)
Country | Link |
---|---|
US (1) | US5861396A (pt) |
EP (1) | EP0771799A1 (pt) |
JP (1) | JPH09124648A (pt) |
KR (1) | KR970027082A (pt) |
AR (1) | AR004545A1 (pt) |
AU (1) | AU720305B2 (pt) |
BR (1) | BR9605434A (pt) |
CA (1) | CA2189401A1 (pt) |
CO (1) | CO4770977A1 (pt) |
CZ (1) | CZ325096A3 (pt) |
DE (1) | DE19541264A1 (pt) |
EE (1) | EE9600172A (pt) |
HU (1) | HU217691B (pt) |
IL (1) | IL119559A0 (pt) |
MX (1) | MX9605371A (pt) |
NO (1) | NO964667L (pt) |
NZ (1) | NZ299683A (pt) |
PL (1) | PL316816A1 (pt) |
SG (1) | SG64953A1 (pt) |
SK (1) | SK142596A3 (pt) |
TR (1) | TR199600883A2 (pt) |
TW (1) | TW360656B (pt) |
ZA (1) | ZA969278B (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE242775T1 (de) * | 1998-01-05 | 2003-06-15 | Eisai Co Ltd | Purinderivate und antagonisten des adenosin-a2- rezeptors, welche zur vorsorge oder heilung von diabetes dienen |
DE19838705A1 (de) | 1998-08-26 | 2000-03-02 | Bayer Ag | Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one |
GB9828340D0 (en) * | 1998-12-22 | 1999-02-17 | Novartis Ag | Organic compounds |
IL139457A0 (en) | 1999-11-08 | 2001-11-25 | Pfizer | Compounds for the treatment of female sexual dysfunction |
US20050020547A1 (en) * | 1999-11-08 | 2005-01-27 | Pfizer Inc. | Compounds for the treatment of female sexual dysfunction |
WO2002009713A2 (de) | 2000-08-01 | 2002-02-07 | Bayer Aktiengesellschaft | Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung |
US20020065286A1 (en) * | 2000-08-21 | 2002-05-30 | Davies Michael John | Treatment of wounds |
US7501409B2 (en) * | 2000-09-06 | 2009-03-10 | Mitsubishi Tanabe Pharma Corporation | Preparations for oral administration |
DE10064105A1 (de) | 2000-12-21 | 2002-06-27 | Bayer Ag | Neue Substituierte Imidazotriazinone |
NZ527585A (en) * | 2001-02-15 | 2005-04-29 | Tanabe Seiyaku Co | Tablets quickly disintegrated in oral cavity |
EP1379520B2 (en) | 2001-02-23 | 2014-04-09 | Merck Sharp & Dohme Corp. | N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
US6479493B1 (en) | 2001-08-23 | 2002-11-12 | Cell Pathways, Inc. | Methods for treatment of type I diabetes |
PL370599A1 (en) * | 2001-11-02 | 2005-05-30 | Pfizer Products Inc. | Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors |
US20060106037A1 (en) * | 2003-03-04 | 2006-05-18 | Thomas Bar | Purin-6-one-derivatives |
US20040220186A1 (en) * | 2003-04-30 | 2004-11-04 | Pfizer Inc. | PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease |
GB0314054D0 (en) * | 2003-06-17 | 2003-07-23 | Pfizer Ltd | Amide derivatives as selective serotonin re-uptake inhibitors |
US20050054688A1 (en) * | 2003-08-08 | 2005-03-10 | Pfizer Inc | Selective serotonin reuptake inhibitors in the treatment of disease |
AU2004268387A1 (en) * | 2003-08-28 | 2005-03-10 | Nycomed Gmbh | Composition comprising a pulmonary surfactant and a PDE2 inhibitor |
US7291640B2 (en) * | 2003-09-22 | 2007-11-06 | Pfizer Inc. | Substituted triazole derivatives as oxytocin antagonists |
GB0409744D0 (en) * | 2004-04-30 | 2004-06-09 | Pfizer Ltd | Novel compounds |
ATE412648T1 (de) * | 2005-03-21 | 2008-11-15 | Pfizer Ltd | Substituierte triazolderivate als oxytocinantagonisten |
JP2008533193A (ja) * | 2005-03-21 | 2008-08-21 | ファイザー・リミテッド | オキシトシン拮抗薬としての置換トリアゾール誘導体 |
EP1917257A1 (en) * | 2005-08-10 | 2008-05-07 | Pfizer Limited | Substituted triazole derivatives as oxytocin antagonists |
WO2015106032A1 (en) | 2014-01-08 | 2015-07-16 | Intra-Cellular Therapies, Inc. | Products and pharmaceutical compositions |
CN107205993B (zh) | 2014-12-06 | 2021-03-09 | 细胞内治疗公司 | 有机化合物 |
AU2015357496B2 (en) | 2014-12-06 | 2019-09-19 | Intra-Cellular Therapies, Inc. | Organic compounds |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4451478A (en) * | 1982-03-12 | 1984-05-29 | Newport Pharmaceuticals International, Inc. | Imidazole compounds |
IL76546A (en) * | 1984-10-12 | 1988-12-30 | Warner Lambert Co | 9-(heteroarylalkyl)-6-purine(thi)one derivatives,their preparation and pharmaceutical compositions containing them |
JPH01501478A (ja) * | 1986-11-25 | 1989-05-25 | インスティテュト オルガニチェスコゴ シンテザ アカデミイ ナウク ラトビイスコイ エスエスアール | 9―置換グアニン |
IT1241452B (it) * | 1990-06-28 | 1994-01-17 | Sigma Tau Ind Farmaceuti | Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono |
-
1995
- 1995-11-06 DE DE19541264A patent/DE19541264A1/de not_active Withdrawn
-
1996
- 1996-10-24 EP EP96117155A patent/EP0771799A1/de not_active Withdrawn
- 1996-10-30 US US08/739,742 patent/US5861396A/en not_active Expired - Fee Related
- 1996-10-31 AU AU70532/96A patent/AU720305B2/en not_active Ceased
- 1996-11-01 NZ NZ299683A patent/NZ299683A/en unknown
- 1996-11-01 CA CA002189401A patent/CA2189401A1/en not_active Abandoned
- 1996-11-04 TW TW085113407A patent/TW360656B/zh active
- 1996-11-04 IL IL11955996A patent/IL119559A0/xx unknown
- 1996-11-04 PL PL96316816A patent/PL316816A1/xx unknown
- 1996-11-05 SG SG1996011041A patent/SG64953A1/en unknown
- 1996-11-05 NO NO964667A patent/NO964667L/no unknown
- 1996-11-05 ZA ZA969278A patent/ZA969278B/xx unknown
- 1996-11-05 EE EE9600172A patent/EE9600172A/xx unknown
- 1996-11-05 MX MX9605371A patent/MX9605371A/es unknown
- 1996-11-05 SK SK1425-96A patent/SK142596A3/sk unknown
- 1996-11-05 KR KR1019960051978A patent/KR970027082A/ko not_active Application Discontinuation
- 1996-11-05 CZ CZ963250A patent/CZ325096A3/cs unknown
- 1996-11-06 TR TR96/00883A patent/TR199600883A2/xx unknown
- 1996-11-06 HU HU9603071A patent/HU217691B/hu not_active IP Right Cessation
- 1996-11-06 CO CO96058501A patent/CO4770977A1/es unknown
- 1996-11-06 BR BR9605434A patent/BR9605434A/pt unknown
- 1996-11-06 JP JP8308604A patent/JPH09124648A/ja active Pending
- 1996-11-06 AR ARP960105076A patent/AR004545A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JPH09124648A (ja) | 1997-05-13 |
HUP9603071A2 (en) | 1997-05-28 |
KR970027082A (ko) | 1997-06-24 |
SK142596A3 (en) | 1997-05-07 |
HU217691B (hu) | 2000-03-28 |
CA2189401A1 (en) | 1997-05-07 |
US5861396A (en) | 1999-01-19 |
AR004545A1 (es) | 1998-12-16 |
BR9605434A (pt) | 1998-08-04 |
EP0771799A1 (de) | 1997-05-07 |
NO964667D0 (no) | 1996-11-05 |
TW360656B (en) | 1999-06-11 |
TR199600883A2 (tr) | 1997-05-21 |
ZA969278B (en) | 1997-06-02 |
EE9600172A (et) | 1997-06-16 |
DE19541264A1 (de) | 1997-05-07 |
CZ325096A3 (en) | 1997-06-11 |
AU720305B2 (en) | 2000-05-25 |
SG64953A1 (en) | 1999-05-25 |
MX9605371A (es) | 1997-05-31 |
NZ299683A (en) | 1998-09-24 |
HU9603071D0 (en) | 1996-12-30 |
CO4770977A1 (es) | 1999-04-30 |
PL316816A1 (en) | 1997-05-12 |
IL119559A0 (en) | 1997-02-18 |
HUP9603071A3 (en) | 1998-04-28 |
AU7053296A (en) | 1997-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO964667L (no) | Purin-6-on-derivater | |
HUT36840A (en) | Process for producing 11-beta-estradiene derivatives and pharmaceutical compositions containing them | |
MX9203762A (es) | Administracion de monoaminacridinas en estados deficientes en colinergicos-neuronales. | |
MY102866A (en) | Amide derivatives. | |
NO954453L (no) | Nye pyridin-, pyrimidin- og benzenderivater som adreno-ceptorantagonister | |
MY101208A (en) | Phenyl-piperazine anti-arrhythmia agents. | |
ATE250623T1 (de) | 4'-c-ethynyl-purin-nukleoside | |
UA41869C2 (uk) | Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування | |
DE3873870T2 (de) | Androstan-17-carbonsaeureester, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten. | |
ATE90676T1 (de) | Dioxyalkylenaryl-dihydropyridine zwischenprodukte zu ihrer herstellung, verfahren zu ihrer herstellung und ihre verwendung. | |
DE68923151T2 (de) | Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen. | |
ATE171374T1 (de) | Verwendung von 1-(aminoalkyl)-3-quinoxalin-2-on derivaten zur herstellung von neuroprotektiven mitteln | |
FI884968A (fi) | Menetelmä lääkeaineena käyttökelpoisten oktahydronaftaleenioksiimin johdannaisten valmistamiseksi | |
ATE233741T1 (de) | Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung | |
ES2152563T3 (es) | Procedimiento para preparar derivados de dihidroxipirimidina. | |
MX9708735A (es) | Benzotiazoles y benzoxazoles, composiciones farmaceuticas que contienen estos compuestos y su uso y proceso para prepararlos. | |
DE3480839D1 (de) | Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung. | |
ATE5961T1 (de) | N-acylpeptid-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
TR200003877T2 (tr) | İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri | |
HUT64302A (en) | Method for producing octahydro-naphtaline-oxime derivatives inhibiting biological synthesis of cholesterol and medical preparatives containing them | |
NO963374L (no) | Substituerte 4H-pyraner | |
AU658175B2 (en) | Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients | |
NO974747L (no) | Fremgangsmåte for fremstilling av streptograminer | |
DE69024154T2 (de) | Pyrimidoindolderivate und Verfahren zu ihrer Herstellung | |
ATE6648T1 (de) | 4h-benzo(4,5)cyclohepta(1,2-b)furanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. |